首页> 外文期刊>The journal of trauma and acute care surgery >Modified Veress needle decompression of tension pneumothorax: A randomized crossover animal study
【24h】

Modified Veress needle decompression of tension pneumothorax: A randomized crossover animal study

机译:改良的Veress针减压气胸减压:随机交叉动物研究

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: The current prehospital standard of care using a large bore intravenous catheter for tension pneumothorax (tPTX) decompression is associated with a high failure rate. We developed a modified Veress needle (mVN) for this condition. The purpose of this study was to evaluate the effectiveness and safety of the mVN as compared with a 14-gauge needle thoracostomy (NT) in a swine tPTX model. METHODS: tPTX was created in 16 adult swine via thoracic CO2 insufflation to 15 mm Hg. After tension physiology was achieved, defined as a 50% reduction of cardiac output, the swine were randomized to undergo either mVN or NT decompression. Failure to restore 80% baseline systolic blood pressure within 5 minutes resulted in crossover to the alternate device. The success rate of each device, death, and need for crossover were analyzed using W2. RESULTS: Forty-three tension eventswere created in 16 swine (24mVN, 19 NT) at 15mmHg of intrathoracic pressure with a mean CO2 volume of 3.8 L. tPTX resulted in a 48% decline of systolic blood pressure from baseline and 73% decline of cardiac output, and 42% had equalization of central venous pressure with pulmonary capillary wedge pressure. All tension events randomized to mVN were successfully rescued within a mean (SD) of 70 (86) seconds. NT resulted in four successful decompressions (21%) within a mean (SD) of 157 (96) seconds. Four swine (21%) died within 5 minutes of NT decompression. The persistent tension events where the swine survived past 5 minutes (11 of 19 NTs) underwent crossover mVN decompression, yielding 100% rescue. Neither the mVN nor the NT was associated with inadvertent injuries to the viscera. CONCLUSION: Thoracic insufflation produced a reliable and highly reproducible model of tPTX. The mVN is vastly superior to NT for effective and safe tPTX decompression and physiologic recovery. Further research should be invested in the mVN for device refinement and replacement of NT in the field.
机译:背景:当前的院前护理标准是使用大口径静脉导管进行张力性气胸(tPTX)减压,这与高失败率相关。我们针对这种情况开发了改良的Veress针(mVN)。这项研究的目的是评估在猪tPTX模型中与14号针头胸腔切开术(NT)相比,mVN的有效性和安全性。方法:通过胸腔二氧化碳注入至15毫米汞柱,在16只成年猪中创建tPTX。达到张力生理(定义为心输出量减少50%)后,将猪随机接受mVN或NT减压。如果未能在5分钟内恢复80%的基线收缩压基线,则会导致进入备用设备。使用W2分析每个设备的成功率,死亡率和交叉需求。结果:16头猪(24mVN,19 NT)胸腔内压力为15mmHg时产生了43次紧张事件,平均CO2量为3.8 L.tPTX导致收缩压较基线下降48%,心脏下降73%输出,并且42%有中心静脉压与肺毛细血管楔压相等。所有随机于mVN的紧张事件均在70(86)秒的平均(SD)内成功获救。 NT在157(96)秒的平均值(SD)内成功进行了四次成功的压缩(21%)。 NT减压后5分钟内有四头猪(21%)死亡。猪存活超过5分钟(19 NT中的11个)的持续紧张事件经历了交叉mVN减压,获得了100%的挽救。 mVN和NT均与内脏的意外伤害无关。结论:胸腔注气可产生可靠且高度可重复的tPTX模型。在有效和安全的tPTX减压和生理恢复方面,mVN远远优于NT。应该在mVN上进行进一步的研究,以在现场改进设备和替换NT。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号